Koru Pharma key facts
as of Oct 2026- Operator of a pharmaceutical company specializing in medical aesthetic products for anti-aging and skin rejuvenation.
- Koru Pharma is valued at approximately $93.7M as of Oct 2026 (last reported valuation).
- It has raised $25.8M; the latest was Secondary Transaction - Private ($17.7M) in Apr 2026.
- Notable investors include IMM Investment, Kolon Investment, Axis Investment, LYFE Capital, DSC Investment — 6 tracked in total.
- Status: Privately Held (backing).
Koru Pharma's last reported valuation, Apr 2026. Nothing priced has surfaced since.
- ·Watch Koru Pharma: the Monday email on marks, rounds and moves
Koru Pharma funding rounds
No funding rounds for Koru Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Koru Pharma
6Koru Pharma valuation
Koru Pharma's last reported valuation was $93.7 million in Apr 2026. No priced round, secondary trade or fund mark has surfaced since.
Koru Pharma investors
6 investors are on record for Koru Pharma, including IMM Investment, Kolon Investment, Axis Investment and LYFE Capital.
About Koru Pharma
Operator of a pharmaceutical company specializing in medical aesthetic products for anti-aging and skin rejuvenation. The company develops and manufactures cosmetological services including anesthetics, mesotherapy, facial masks, body fillers, cosmeceutical, helping maintain the beauty, youth and health of people.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2016
- Employees
- 61
- Website
- korupharma.co.kr/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.